Company Profile
Updated: 27-OCT-09Gamida-Cell Ltd.
International Private company
PO Box 34670, 5 Nahum Hafzadi St., Beit Ofer, Jerusalem, 91340, Israel
()972 02 659 5666, 972 02 659 5616 fax, http://www.gamida-cell.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Biotechnology company specialising in the development of bio-pharmaceutical products based on its proprietary stem cell expansion technology for use in bone marrow transplants as well as cardiac and pancreatic repair. The company's first commercial product is expected to be registered in 2007
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
StemEx Noted as a Reliable Investigational Product of an Expanded Population of Stem Cells at Umbilical Cord Blood Symposium in Israel.
Blood Weekly; 11/19/2009; 952 words; ...lymphoma (see also Gamida Cell Ltd). Professor...sponsored by the Gamida Cell-Teva Joint...marrow. And, cell dose is the most...amount of stem cells. We think that...significantly more stem cells." He continued...Oncology, Stem Cell Research, ...
StemEx[R] Noted as a Reliable Investigational Product of an Expanded Population of Stem Cells at Umbilical Cord Blood Symposium in Israel.
Blood Weekly; 11/19/2009; 924 words; ...to bone marrow. And, cell dose is the most critical...of the amount of stem cells. We think that StemEx...significantly more stem cells." He continued...Lymphoma, Oncology, Stem Cell Research, Surgery...Medicine, Transplantation, Gamida Cell Ltd. This article was prepared...
Gamida Cell and Cellerix Partner on Feasibility Study.
Blood Weekly; 11/5/2009; 729 words; Gamida Cell Ltd. and Cellerix...Research). Gamida Cell is developing...progenitor cells that display...hematopoietic stem cells. Combining the...a new line of cell therapeutics...Transfusion Medicine, Gamida Cell Ltd. This article...
Other News To Note.
BIOWORLD Today; 11/3/2009; 3245 words; ...zonisamide) to Eisai Co. Ltd., of Tokyo. In exchange...in adult epilepsy. o Gamida-Cell Ltd., of Jerusalem, said...populations of human stem cells improves cardiac function...self-renewal of stem cells. o Genmab A/S, of...Phase II cutaneous T-cell lymphoma studies (CTCLs...
Hurdles Remain For Successful Commercialization Of Stem Cells.
BIOWORLD Today; 11/3/2009; 1171 words; ...understanding of how cells interact with their microenvironments...markers for predicting cell state and fate, questions about where cells go after they are implanted...Chris Mason, of the Stem Cell and Regenerative Medicine...The Israeli firm Gamida Cell Ltd. is about to ...
Recent News Articles
- Elbit Medical Imaging Ltd. Announces That Elscint Holding Gamida-Cell and Teva Will Develop and Commercialize StemEx(R) for the Treatment of Leukemia.
PR Newswire - February 21, 2005 - CEO INTERVIEW: EHUD MAROM - GAMIDA-CELL LTD.(Brief Article)
Wall Street Transcript Digest - October 21, 2003 - Gamida-Cell Ltd. Announces Official Start of its Israel Stem Cell Therapy Consortium Projects.
Business Wire - September 25, 2003 - Gamida-Cell Ltd. Announces Phase I Trial of StemEx for the Treatment of Leukemia and Lymphoma Patients; Clinical Trial to Commence at M.D. Anderson Cancer Center in Houston, Texas.
Business Wire - February 12, 2003
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning